CLINICAL ROLE -
The Cost of Low Health Literacy
We all have a general idea of what low health literacy is, but do we really know how much it costs?
Read More
CDC, FDA Investigating After Dead Bat Found in Packaged Salad Product
An investigation is ongoing after packaged salads purchased from a grocery store in Florida were found to contain a dead bat.
Biosimilar Trends Highlight AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
AACR Annual Meeting Highlights Week in Cancer News
Top news of the week in oncology and cancer drug development.
Five Rights Framework Seeks to Improve Dysfunction in Specialty Drug Marketplace
Newly developed framework offers a common ground for specialty pharmacy stakeholders.
Investigational Compound Observed to Render Superbugs Harmless
Antivirulence compounds can prevent superbugs from producing toxins and forming infections.
Combination Hepatitis C Therapy Wins FDA Approval for Pediatric Patients
Sovaldi plus Harvoni approved to treat HCV in children ages 12 to 17.
FDA Approves Hepatitis C Combo Treatment for Pediatric Patients
Sovaldi plus Harvoni is the first direct-acting antiviral treatment approved for children and adolescents aged 12 to 17.
US District Court Invalidates 4 Patents for Multiple Sclerosis Drug Ampyra
Dalfampridine is the only FDA-approved drug to aid walking in patients with MS.
Prime Therapeutics to Manage Specialty Drug Benefits for Government Employees
Pharmacy benefit manager takes CVS Health’s role in providing specialty drug management for Federal Employee Program.
Federal Employee Program Switches Managers of Specialty Drug Program
Pharmacy benefit manager Prime Therapeutics takes over providing specialty pharmacy services from CVS Health for the Blue Cross Blue Shield Federal Employee Program.
Millennials Value Health Insurance Benefits Over Pay Raises
Health insurance considered more important than data plans for smartphones among millenials.
Statins Observed to Improve Chronic Liver Disease
Statin use may prevent hepatocellular carcinoma in patients with chronic liver disease.
FDA Approves First Direct-to-Consumer Genetic Tests
The 23andME Personal Genome Service Genetic Health Risk can identify genetic risks for 10 diseases.
Potential Therapeutic Target Identified for Aggressive Pancreatic Cancer
Small molecule inhibition of PRMT1 may be an effective therapeutic strategy in pancreatic cancer.
Severe Psoriasis May be More Common in Men
Women observed to have significantly lower Psoriasis Area Severity Index scores than men.
FDA Approves 2 Hepatitis C Drugs for Use in Pediatric Patients
The FDA approved supplemental applications for Sovaldi (sofosubuvir) and Harvoni (ledipasvir and sofosbuvir), marketed by Gilead Sciences Inc., to treat hepatitis C virus (HCV) in pediatric patients.
Novel Method Fingerprints HIV
Technique will help scientists develop an effective HIV vaccine.
Continued Immunotherapy Could Be Effective Despite Progression
Stopping immunotherapy after tumor growth may lead to lower survival.
Discontinuing Ineffective Immunotherapy May Reduce Cancer Survival Rate
Study finds halting immunotherapy after disease progression in head and neck cancer may not be the best strategy.
Inflammatory Bowel Disease Linked to Fatty Liver Disease?
Patients with inflammatory bowel disease (IBD) are at a higher risk of developing nonalcoholic fatty liver disease (NAFLD), a recently-published study concluded.
Risk of Bladder, Kidney Stone Disease Higher in Patients with Multiple Sclerosis
Patients with MS have a high incidence of calcium phosphate stones and struvite stones, study finds.
Biosimilar Trends Highlight Top News of the Week in Specialty Pharmacy
Top 5 most read articles this week from Specialty Pharmacy Times.
Trending News Today: FDA Approves Genetic Test for Personal Disease Risk
Top news of the day from across the health care landscape.
Blood Biomarker May Indicate Development of Type 1 Diabetes
Presence of 12-HETE found in the blood of patients with newly-onset diabetes.
Trending News Today: AHCA Amendment Would Provide Federal Funding for Costly Customers
Top news of the day from across the healthcare landscape.
Follow the Leader: Emulate Pharmacists' Work in Diabetes Clinical Trials
Medication adherence among patients with diabetes, even those who are enrolled in and closely supervised by clinical trials, is often poor.
NCPA Supports House Bill Improving Pharmacy Choice for Seniors in Part D Plans
The Road Ahead for Biosimilars in 2017 Holds Multiple Challenges to Overcome
Amgen’s 2017 Trends in Biosimilars report examines commercialization and distribution issues in the biosimilar space.
Biosimilar Trends Report Shows Significant Progress and Challenges
Legal challenges, drug shortages, and regulatory issues create hurdles for biosimilars in the US market.
